The lifetime risk of TB reactivation is 20% among HIVinfected people, which is defined by a 10-mm or greater TANAFFOS induration in a tuberculin skin test (TST). A TST reaction, using purified protein derivative (PPD) in the Mantoux technique, is useful method for latent tuberculosis infection (LTBI) screening (7) . However, this test is reported to be less sensitive among HIV-positive patients with low CD4 positive lymphocyte counts (8) .
This study aimed to evaluate the TST reaction and its yearly conversion in HIV-infected persons who had CD4 counts ≥200 cells/µL and were TST-negative at the beginning of combined anti-retroviral therapy (c-ART) in a Consultation Centre for Clients with Risky Behaviors in Imam Khomeini Teaching Hospital. were included in our study.
MATERIALS AND METHODS

This
The mean age of the patients was 37.82 ± 9.11 years.
Demographic data are shown in Table 1 . At 1 year, 9 of the 113 (8%) TST-negative patients turned TST-positive after taking c-ART. The incidence rate for TST conversion was 10.09/100 person-years. The baseline patient characteristics for TST converters and non-converters are shown in Table 2 . In our study population, there was no association between CD4 cell count increment, baseline CD4 cell count, and TST conversion. Of the demographic characteristics, only female sex was found to be associated with TST conversion. Radiologic findings, history of IPT, and history of TB disease/treatment were not associated with TST conversion. CD4 cell count and its increment after 12 months were significantly different between females and males ( Table 3 ).
All of our patients had a history of Bacille CalmetteGuerin vaccination. No patients developed active TB during the 1-year follow-up period.
DISCUSSION
In this study over a period of 12 months after c-ART initiation, 9 of 113 (8%) TST-negative patients experienced TST conversion-an incidence rate of 10.09/100 personyears. We found a lower rate of TST conversion than other studies (6,7). These conversions were not related to the reversal of anergy due to c-ART because the CD4 count in our study population was >200 cells/µL at baseline. is a weak point of our study.
Our study found no association between chest radiograph abnormalities and PPD conversion rates (odds ratio: 0.77, 95% confidence interval: 0.08-7.05, p = 0.59), which is in line with a study from Uganda (6). In another study, the majority of participants with positive TST results had a negative chest radiograph; these authors concluded that chest radiography does not demonstrate the benefit of IPT for clinicians (12) . To the best of our knowledge, no studies have shown that an abnormal chest x-ray is a risk factor for PPD conversion.
In contrast to a previous study (6), we found that the rate of PPD conversion was significantly higher for males (Table 2) . Female sex was independently associated with negative TSTs among HIV-infected adults in Thailand (13) .
Another study reported that 66-75% of patients with TB in 12 Asian countries were male; therefore, men may account for approximately two-thirds to three-quarters of the burden of TB disease in Asia (14) . In China, Gao et al.
found that LTBI rates were higher in men than in women (p < 0.0001) (15) . These reports indicate that men may be more susceptible to TB than women. It remains unclear if male sex is a risk factor for TB. In addition to behavioral factors (e.g., smoking, alcohol, and drug use), biological components also should be considered (16) . One study indicated that estradiol acts as an immunity-enhancing mediator in women, with testosterone acting as a mediator inhibiting the immune response (17) .
In line with a previous study (18) , the women in our study had higher mean CD4 cell counts than men after 1 year of antiretroviral therapy (p < 0.001). More frequent side effects were also reported for all classes of antiretrovirals in women (19) . Other studies concluded that virologic suppression was achieved more rapidly in women and the response was more durable; therefore, women may experience more benefits for outcomes than men (20, 21) .
Oni et al. reported an 8.5% prevalence rate for asymptomatic TB disease among HIV-infected persons.
The authors showed that 61% of patients with subclinical TB had a CD4 count of >200 cells/µL; however, a low CD4 count appeared to be predictive of subclinical TB (22) . The TST conversion in some of our patients could be due to subclinical active TB. All of our participants were screened for TB symptoms (cough, fever, weight loss, and night sweats). However, we did not collect sputum samples for microscopy and culture, which is a weak point of our study.
Some studies reported that IPT caused a greater reduction in the risk of active TB for TST-positive HIVinfected adults than in TST-negative adults (11, 23) . In our study, we found a low incidence of TST conversion. 
